Demetra Launches Global Spine Division with Acquisition of OrthoFundamentals

Demetra to Launch a New Global Spine Division by Acquiring Orthofundamentals LLC

Announcement

Demetra, a well-established and innovative international medical company, and a leader in spacers, biomaterials, and bone cements for PJI infection control and orthopedic applications, has acquired Orthofundamentals LLC, a popular US-based company with sterile-packed and creative implants and single-use instrument kits for SI joint fusion. With this acquisition, Demetra introduced Demetra Spine, a new worldwide business unit for transforming spinal surgery with its robust value-based solutions. Demetra’s new business move will accelerate the healthcare sector globally.

The Effectiveness of the Acquisition for Demetra

The acquisition bolsters and strengthens Demetra’s clinical trial and technology in spine surgery. The number of acquisitions of Getset Surgical, a Swiss fame in sterile-packed single-use spine procedure kits, and a smart asset purchase from bespoke technologies introduced groundbreaking sterile-packed 3D-printed titanium implants for ACDF procedures.

Demetra served 40 years of support to the healthcare professionals globally in orthopedics, enhancing the patient’s lives of around 3 million individuals via advanced solutions in prosthesis fixation, orthobiologics, and infection control. The success of Tecres, osteoRemedies, and osartis technology solutions. Continuing on this legacy, the company is all set to expand its presence and impact on spinal surgery through these acquisitions, representing Demetra Spine with a scientific, technological, and engineering unique foundation to primarily meet market needs and ease difficult challenges in the field.

Views and Statements

Founder and CEO of OrthoFundamentals, Mathew Palmer, said, “There was a joint Vision and natural synergy between Demetra and us to stand unique in the market by identifying the first-ever pain points noticed and experienced by providers of spine surgical solutions, mainly in the outpatient ASC settings. We are thrilled to have Demetra’s spine team on board and a chance to leverage this vision to rule by differentiated fundamentalism with single-use solutions that are consistently sterile, ready, and sharp.”

Vice president of Demetra Spine, North America, Ted Bird said, “Demetra introduces an engaging and innovative portfolio of surgery-in-a-box procedural kits ready in the market for quick use in hospital operating rooms and ASC, designed to elevate productivity, diminish risk of surgical site infections, and serve value by discarding reprocessing and sterilization.” Further, Ted added, “Our motive is to earn a leadership position in the immensely expanding outpatient spine surgery segment by forming a versatile, market-centralized organization, serving exceptional products and services that will be a huge support to our customers.”